Literature DB >> 19296791

Supraventricular tachycardia.

Caroline Medi1, Jonathan M Kalman, Saul B Freedman.   

Abstract

Supraventricular tachycardia (SVT) is a common cardiac rhythm disturbance; it usually presents with recurrent episodes of tachycardia, which often increase in frequency and severity with time. Although SVT is usually not life-threatening, many patients suffer recurrent symptoms that have a major impact on their quality of life. The uncertain and sporadic nature of episodes of tachycardia can cause considerable anxiety - many patients curtail their lifestyle as a result, and many prefer curative treatment. SVT often terminates before presentation, and episodes may be erroneously attributed to anxiety. Sudden-onset, rapid, regular palpitations characterise SVT and, in most patients, a diagnosis can be made with a high degree of certainty from patient history alone. Repeated attempts at electrocardiographic documentation of the arrhythmia may be unnecessary. Treatment of SVT may not be necessary when the episodes are infrequent and self-terminating, and produce minimal symptoms. When episodes of tachycardia occur frequently, are prolonged or are associated with symptoms that affect quality of life, catheter ablation is the first choice of treatment; it is a low-risk procedure with a high success rate. Long-term preventive pharmacotherapy is an alternative approach in some patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296791     DOI: 10.5694/j.1326-5377.2009.tb02388.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  13 in total

1.  Carotid body function in aged rats: responses to hypoxia, ischemia, dopamine, and adenosine.

Authors:  Teresa Castro Monteiro; Joana Rita Batuca; Ana Obeso; Constancio González; Emília Carreira Monteiro
Journal:  Age (Dordr)       Date:  2010-10-05

Review 2.  Diagnosis and management of supraventricular tachycardias.

Authors:  Lior Bibas; Michael Levi; Vidal Essebag
Journal:  CMAJ       Date:  2016-10-24       Impact factor: 8.262

Review 3.  [Psychosomatic aspects of cardiac arrhythmias].

Authors:  Martin Siepmann; Wilhelm Kirch
Journal:  Med Klin (Munich)       Date:  2010-07-30

Review 4.  Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia.

Authors:  Gavin D Smith; Meagan M Fry; David Taylor; Amee Morgans; Kate Cantwell
Journal:  Cochrane Database Syst Rev       Date:  2015-02-18

Review 5.  Current trends in supraventricular tachycardia management.

Authors:  Daniel Sohinki; Owen A Obel
Journal:  Ochsner J       Date:  2014

6.  Next-generation sequencing of AV nodal reentrant tachycardia patients identifies broad spectrum of variants in ion channel genes.

Authors:  Laura Andreasen; Gustav Ahlberg; Chuyi Tang; Charlotte Andreasen; Jacob P Hartmann; Jacob Tfelt-Hansen; Elijah R Behr; Steen Pehrson; Stig Haunsø; Peter E Weeke; Thomas Jespersen; Morten S Olesen; Jesper H Svendsen
Journal:  Eur J Hum Genet       Date:  2018-02-02       Impact factor: 4.246

7.  Development and initial psychometric evaluation of the Patient Perspective of Arrhythmia Questionnaire.

Authors:  Kathryn A Wood; Anita L Stewart; Barbara J Drew; Melvin M Scheinman; Erika S Frolicher
Journal:  Res Nurs Health       Date:  2009-10       Impact factor: 2.228

Review 8.  Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.

Authors:  Samer Alabed; Ammar Sabouni; Rui Providencia; Edmond Atallah; Mohammed Qintar; Timothy Ja Chico
Journal:  Cochrane Database Syst Rev       Date:  2017-10-12

9.  Position paper on the importance of psychosocial factors in cardiology: Update 2013.

Authors:  Karl-Heinz Ladwig; Florian Lederbogen; Christian Albus; Christiane Angermann; Martin Borggrefe; Denise Fischer; Kurt Fritzsche; Markus Haass; Jochen Jordan; Jana Jünger; Ingrid Kindermann; Volker Köllner; Bernhard Kuhn; Martin Scherer; Melchior Seyfarth; Heinz Völler; Christiane Waller; Christoph Herrmann-Lingen
Journal:  Ger Med Sci       Date:  2014-05-07

10.  A model for priority setting of health technology assessment: the experience of AHP-TOPSIS combination approach.

Authors:  Mohammadreza Mobinizadeh; Pouran Raeissi; Amir Ashkan Nasiripour; Alireza Olyaeemanesh; Seyed Jamaleddin Tabibi
Journal:  Daru       Date:  2016-04-11       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.